Proteomics-Based Analysis of Stress Responses During Recombinant Protein Production in Escherichia Coli''

Total Page:16

File Type:pdf, Size:1020Kb

Proteomics-Based Analysis of Stress Responses During Recombinant Protein Production in Escherichia Coli'' PROTEOMICS-BASED ANALYSIS OF STRESS RESPONSES DURING RECOMBINANT PROTEIN PRODUCTION IN ESCHERICHIA COLI Inauguraldissertation zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) der Mathematisch-Naturwissenschaftlichen Fakultät der Universität Greifswald vorgelegt von Katarzyna Magdalena Dolata geboren am 11.11.1989 in Poznań Greifswald, den 21.03.2019 1 Dekan: Prof. Dr. Werner Weitschies 1. Gutachter: Prof. Dr. Katharina Riedel 2. Gutachter: Prof. Dr. Wolfgang Liebl Tag der Promotion: 18.07.2019 2 Dedicated to my family and friends 3 4 Table of contents Table of contents Abstract .................................................................................................................................... 9 Zusammenfassung................................................................................................................. 10 Acknowledgements ............................................................................................................... 11 Original publications ............................................................................................................ 13 List of tables........................................................................................................................... 14 List of figures ......................................................................................................................... 15 Abbreviations ........................................................................................................................ 18 Introduction ................................................................................................................... 21 1.1 Overview of the recombinant therapeutic protein market ...................................... 21 1.2 E. coli as a favored bacterial host for recombinant protein production .................. 25 1.3 Strategies for the production of recombinant proteins in E. coli ............................ 28 1.3.1 Optimization of the protein expression vector .................................................. 30 1.3.2 Targeted expression of recombinant proteins ................................................... 32 1.3.3 Induction strategy.............................................................................................. 35 1.4 Cellular stress induced by recombinant protein production in E. coli .................... 36 1.5 Novel E. coli strains enhancing heterologous protein production .......................... 41 1.6 Application of proteomics to study protein production stress ................................ 43 Scope of the thesis ......................................................................................................... 46 Results ............................................................................................................................ 47 3.1 Cellular consequences of Tat pathway deletion in E. coli ...................................... 47 3.1.1 Loss of Tat function has a major impact on cell morphology .......................... 47 3.1.2 Proteome changes linked to the loss of Tat export ........................................... 49 5 Table of contents 3.2 Stress responses related to recombinant protein production and Tat-dependent secretion ................................................................................................................. 55 3.2.1 Production of scFv antibody in the oxidative cytoplasm .................................. 55 3.2.2 Co-expression of hGH with Tat system components ....................................... 65 3.3 Proteome changes under tunable recombinant protein expression and Sec- dependent secretion ................................................................................................ 78 3.3.1 Stress responses related to hGH expression and secretion via Sec system....... 80 3.3.2 Proteome changes associated with an excessive expression induction ............ 86 Discussion....................................................................................................................... 88 4.1 The Tat pathway has an important role in cell division and maintaining cell wall integrity in E. coli ................................................................................................... 88 4.2 Effect of foreign protein synthesis on growth kinetics ........................................... 90 4.3 Metabolic responses to protein overexpression ...................................................... 91 4.4 Recombinant protein overexpression suppresses periplasmic secretion of host's proteins ................................................................................................................... 95 4.5 Cell envelope stress and alterations of membrane integrity ................................... 98 4.6 Oxidative stress and redox regulation in the cytoplasm ......................................... 99 4.7 Proteostasis control by the protein production response....................................... 101 4.8 Cell adhesion mediated by misfolded protein production .................................... 103 Conclusions .................................................................................................................. 104 6 Materials and methods ............................................................................................... 105 6.1 Bacterial strains and plasmids ............................................................................... 106 6.2 Microbiological techniques ................................................................................... 107 6.2.1 Bacterial culture preservation ......................................................................... 107 6 Table of contents 6.2.2 Cell cultivation and recombinant protein expression...................................... 108 6.2.3 Transformation of E. coli ................................................................................ 110 6.3 Physiological assays.............................................................................................. 112 6.3.1 Monitoring of bacterial growth ....................................................................... 112 6.3.2 Biofilm formation ........................................................................................... 113 6.3.3 Colanic acid quantification ............................................................................. 113 6.3.4 Cell aggregation .............................................................................................. 114 6.4 Microscopy ........................................................................................................... 114 6.4.1 Transmission electron microscopy ................................................................. 114 6.4.2 Phase contrast microscopy .............................................................................. 115 6.5 Sample preparation for mass spectrometry ........................................................... 115 6.5.1 Subcellular fractionation and protein extraction ............................................. 115 6.5.2 Protein precipitation ........................................................................................ 117 6.5.3 Determination of protein concentration .......................................................... 117 6.5.4 Electrophoresis (SDS-PAGE) ......................................................................... 117 6.5.5 In-gel protein digestion ................................................................................... 118 6.5.6 In-solution protein digestion ........................................................................... 119 6.6 Analytical methods ............................................................................................... 119 6.6.1 Western Blot ................................................................................................... 119 6.6.2 LC-MS analysis .............................................................................................. 120 6.7 Bioinformatic analysis of proteomic data ............................................................. 123 6.7.1 Statistical analysis ........................................................................................... 123 6.7.2 Protein annotation ........................................................................................... 123 7 Table of contents 6.7.3 Graphical presentation .................................................................................... 124 6.7.4 Data deposition ............................................................................................... 124 References .................................................................................................................... 125 Appendix ...................................................................................................................... 139 8.1 CD-ROM contents ................................................................................................ 139 8.2 Protein and peptide sequences .............................................................................. 140 8.3 Equipment and consumables................................................................................. 142 8.4 Reagents and chemicals ........................................................................................ 145 8.5 Software ...............................................................................................................
Recommended publications
  • The Rcs Phosphorelay May Regulate the E. Coli Capsule Response to Sublethal Streptomycin Treatment
    Journal of Experimental Microbiology and Immunology (JEMI) Copyright © April 2015, M&I UBC The Rcs Phosphorelay May Regulate the E. coli Capsule Response to Sublethal Streptomycin Treatment Iris Luo, Josh Wiebe, Yunan Liu Department of Microbiology and Immunology, University of British Columbia The Escherichia coli colanic acid capsule produced by the cps gene confers resistance in the presence of sublethal antibiotic concentrations. However, the exact mechanism of capsule gene regulation in reaction to the presence of antibiotics is unknown. The two main proposed cps regulation pathways both involve the Rcs phosphorelay system, but differ regarding dependence on RpoS for cps transcription. In this study, we explored the changes in capsule formation and antibiotic resistance in response to treatment with sublethal concentrations of streptomycin using deletion mutants of the two proposed regulation pathways. Wild type, Δ rcsB, Δ rpoS, and Δ cps. E. coli strains were incubated in sublethal concentrations of streptomycin. When examined with MIC assays, the deletion mutants showed higher levels of antibiotic resistance compared to wild type strains of E. coli. We also demonstrated that capsule production was induced under sublethal streptomycin conditions with Maneval staining. Furthermore, qPCR detection of cps transcription indicated downregulation in Δ rcsB strains and upregulation in Δ rpoS after streptomycin treatment. Together, these results suggest that E. coli streptomycin resistance is not dependent on capsule production, and that rcsB and rpoS may both play a role in cps regulation when treated with sublethal doses of streptomycin. Escherichia coli are rod shaped bacteria capable of producing a polysaccharide capsule. The capsule is important for protection from desiccation, survival during oxidative stress, bacterial virulence, and antibiotic resistance (1).
    [Show full text]
  • Current Topics in Microbiology and Immunology
    Current Topics in Microbiology and Immunology Volume 431 Series Editors Rafi Ahmed School of Medicine, Rollins Research Center, Emory University, Atlanta, GA, USA Shizuo Akira Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan Klaus Aktories Faculty of Medicine, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Baden-Württemberg, Germany Arturo Casadevall W. Harry Feinstone Department of Molecular Microbiology & Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA Richard W. Compans Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA Jorge E. Galan Boyer Ctr. for Molecular Medicine, School of Medicine, Yale University, New Haven, CT, USA Adolfo Garcia-Sastre Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA Bernard Malissen Parc Scientifique de Luminy, Centre d‘Immunologie de Marseille-Luminy, Marseille, France Rino Rappuoli GSK Vaccines, Siena, Italy The review series Current Topics in Microbiology and Immunology provides a synthesis of the latest research findings in the areas of molecular immunology, bacteriology and virology. Each timely volume contains a wealth of information on the featured subject. This review series is designed to provide access to up-to-date, often previously unpublished information. 2019 Impact Factor: 3.095., 5-Year Impact Factor: 3.895 2019 Eigenfaktor Score: 0.00081, Article Influence Score: 1.363 2019 Cite Score: 6.0, SNIP: 1.023, h5-Index: 43 More
    [Show full text]
  • Systemic Infection Induced by Campylobacter Jejuni: Development of a Mouse Model and Elucidation of Molecular Mechanisms Samantha Terhorst Iowa State University
    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2012 Systemic infection induced by Campylobacter jejuni: Development of a mouse model and elucidation of molecular mechanisms Samantha Terhorst Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Microbiology Commons Recommended Citation Terhorst, Samantha, "Systemic infection induced by Campylobacter jejuni: Development of a mouse model and elucidation of molecular mechanisms" (2012). Graduate Theses and Dissertations. 12653. https://lib.dr.iastate.edu/etd/12653 This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Systemic infection induced by Campylobacter jejuni: Development of a mouse model and elucidation of molecular mechanisms by Samantha Ashley Terhorst A thesis submitted to the graduate faculty in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Major: Toxicology Program of Study Committee: Qijing Zhang, Major Professor Byron Brehm-Stecher Paul Plummer Orhan Sahin Iowa State University Ames, Iowa 2012 Copyright © Samantha Ashley Terhorst, 2012. All rights reserved. ii TABLE OF CONTENTS ABSTRACT .....................................................................................................................
    [Show full text]
  • A Brief History of the Family of Sonja Escherich-Eisenmenger-Weber
    A Brief History of the family of Sonja Escherich-Eisenmenger-Weber © Copyright 1990 Ernst Weber, Tryon, North Carolina Part I Pfaundlers, Oetz and Piburg Part II Theodor Eseherich and Child Care in Vienna Part III Sonya Escherich-Eisenmenger, 1895 until 1936 Privately Printed By M.A. DESIGNS Tryon, NC An Introduction to Sonya & Ernst Weber An address by James M. Flack (son-in-law of Sonya Weber) at the Cosmos Club in Washington, D.C. Tuesday, October 14, 1975 on the occasion of the establishment of the Sonya & Ernst Weber Scholarship Fund. Dr. Bugliarello, Friends, Associates and Family of Sonya and Ernst Weber. It is my honor and privilege to speak on behalf of the dose members of the Weber family. Dr. Bugliarello, we are grateful to you and to Polytechnic for establishing the Sonya and Ernst Weber Scholarship Fund. The criterion for the awards - based on excellence and regardless of need is most appropriate. This is consonant with the lives of the Webers. They have searched for the good - for things of real value. And when things of value were discovered, they were able to recognize, cherish, nurture and reward them to assure their continuity and growth. Sonya and Ernst Weber are well known - both nationally and internationally, each in her and his own field. They have each been showered with honors for their achievements and contributions to a better way of life in our time and for the future to come - Ernst in the field of science as a physicist, engineer, educator and administrator; Sonya also in the field of science as a doctor of physical medicine and physical fitness.
    [Show full text]
  • Issue 2, September 2011
    Quarterly Newsletter of the Belgian Society for Microbiology Issue no. 2, September 2011 Contents Welcome by the president of BSM Page 1 As indicated in the program, the morning session Membership Page 2 consists of 4 plenary lectures, while in the News from FEMS Page 2 afternoon 2 parallel sessions (bacteriology, BSM Symposium 2011 Page 3 virology) are programmed with time reserved for Theodor Escherich Page 5 short oral communications from selected Report on MRM Symposium Page 7 abstracts. PhD Corner Page 9 Call for contributions Page 10 Besides this, there will be also ample time to Composition of the BSM board Page 10 discuss during the posters session. As such this meeting is also meant as an opportunity to meet microbiology colleagues and to exchange ideas. More details of the symposium, and how to Welcome register, you will find on p 3. Concomitantly with the start of the new academic year, we send you Issue 2 of the E-Newsletter of the We also started with a series of short overviews Belgian Society for Microbiology. Since the first E- on historical data in microbiology (see p 4), and Newsletter, the BSM board was further active in continue with the PhD corner, and report on FEMS several respects. sponsored activities. The BSM Board has further worked on finalizing the BSM was also for the first time host of the FEMS th program of the symposium (Brussels, 16th November Council meeting held in Leuven 16-17 2011), the yearly most important activity of BSM. September, which was attended by 37 delegates (22 different nationalities) representing different This year’s topic is “Live, death and survival of Micro- microbiological societies unified under the organisms” emphasizing that thanks to the umbrella of FEMS, which altogether represent continuous progress in microbiological sciences, more than 30000 European microbiologists (see strategies used by micro-organisms to live and http://www.fems-microbiology.org).
    [Show full text]
  • Bacillus Subtilis
    Das Phagenschock-Protein LiaH aus Bacillus subtilis Dissertation der Fakultät für Biologie der Ludwig-Maximilians-Universität München Vorgelegt von aus Leisnig München April 2012 1. Gutachter: Prof. Dr. Thorsten Mascher 2. Gutachterin: Prof. Dr. Ute Vothknecht Tag der Abgabe: 10.04.2012 Tag der mündlichen Prüfung: 31.10.2012 Eidesstattliche Versicherung und Erklärung Hiermit versichere ich an Eides statt, dass die vorliegende Dissertation von mir selbständig und ohne unerlaubte Hilfe angefertigt wurde. Zudem wurden keine anderen als die angegebenen Quellen verwendet. Außerdem versichere ich, dass die Dissertation keiner anderen Prüfungskommission vorgelegt wurde und ich mich nicht anderweitig einer Doktorprüfung ohne Erfolg unterzogen habe. München, den 10.04.2012 ____________________________ Diana Wolf „Nichts beflügelt die Wissenschaft so, wie der Schwatz mit Kollegen auf dem Flur.“ Arno Penzias (*1933), amerik. Physiker, 1978 Nobelpreis Inhaltsverzeichnis Inhaltsverzeichnis Publikationsliste IV Abkürzungsverzeichnis V Zusammenfassung VII Summary IX Kapitel I: Einleitung 1 I.1. Aufbau der bakteriellen Zellwand 1 I.2. Zellwandbiosynthese 2 I.3. Die Zellwand als Ziel von antibiotisch wirkenden Substanzen 5 I.4. Die Zellhüllstressantwort in Gram-positiven Bakterien am Beispiel B. subtilis 8 I.5. Das LiaFSR-Dreikomponentensystem in B. subtilis 11 I.5.1. Induktion des LiaFSR-3KS 12 I.5.2. Regulation und Funktion des LiaFSR-3KS 12 I.6. Die Zellhüllstressantwort in Gram-negativen Bakterien am Beispiel E. coli 14 I.7. Die Phagenschock-Antwort in E. coli 16 I.7.1. Induktion der Phagenschock-Antwort 17 I.7.2. Regulation der Phagenschock-Antwort 18 I.7.3. Rolle der Phagenschock-Antwort im Energiestoffwechsel 20 I.8. Die Phagenschock-Antwort in anderen Organismen 20 I.8.1.
    [Show full text]
  • 5Th Theodor Escherich & 2Nd AMICI Joint Symposium
    5th Theodor Escherich & 2nd AMICI Joint Symposium 8th - 9th November 2018 Neuer Med Campus, Neue Stiftingtalstraße 2 Medical University of Graz, Austria ABSTRACT BOOK If you do’t like iroes, you’re o the rog plaet (Stewart Brand, adapted) In behalf of the organizing committee of the 5th Theodor Escherich & 2nd AMICI Joint Symposium 2018 we cordially welcome you at the Medical University of Graz. We are very pleased with the high number of renowned national and international scientists oerig the topis iroioe ad aer, iroioe ad utritio, iroioe ad eiroet, egleted eers of the hua iroioe, iroiota odulatio ad the plat iroioe that hae aepted our iitatio to speak. We will have more than 200 guests from Austria and Europe, interested interdisciplinary microbiome research. The new Campus at the Medical University in Graz provides an excellent venue for this event, and we are convinced that the wonderful atmosphere in this building will support personal exchange and discussion amongst young researchers and PIs. We are particularly thankful for the fruitful interaction with the Austrian Microbiome Initiative AMICI, serving as an excellent networking platform for microbiome research – resulting in this joint adventure this year! We are extremely grateful for the generous support from our sponsors and industry partners. We are looking forward to a very fruitful meeting, The local organizing committee Gabriele Berg Gregor Christoph Robert Krause, Christine Moissl- TU Graz Gorkiewicz, MUG Högenauer, MUG MUG Eichinger, MUG www.medunigraz.at/microbiome Sehr geehrte Damen und Herren, liebe Kolleginnen und Kollegen! Bakterien, Viren, Archaen, Parasiten und Pilze – unseren Körper teilen wir mit Billionen Bakterien, die Mundhöhle, Haut und Darm besiedeln.
    [Show full text]
  • Interplay of Virulence, Antibiotic Resistance and Epidemiology in Escherichia Coli Clinical Isolates
    Interplay of virulence, antibiotic resistance and epidemiology in Escherichia coli clinical isolates Elisabet Guiral Vilalta Aquesta tesi doctoral està subjecta a la llicència Reconeixement- NoComercial – SenseObraDerivada 4.0. Espanya de Creative Commons. Esta tesis doctoral está sujeta a la licencia Reconocimiento - NoComercial – SinObraDerivada 4.0. España de Creative Commons. This doctoral thesis is licensed under the Creative Commons Attribution-NonCommercial- NoDerivs 4.0. Spain License. Facultat de Medicina Departament de Fonaments Clínics Programa de Doctorat de Medicina i Recerca Translacional “Interplay of virulence, antibiotic resistance and epidemiology in Escherichia coli clinical isolates” Doctoranda: Elisabet Guiral Vilalta Departament de Fonaments Clínics Institut de Salut Global de Barcelona‐ Universitat de Barcelona‐ Hospital Clínic de Barcelona Directors de tesi: Dr. Jordi Vila Estapé i Dra. Sara M. Soto González Departament de Fonaments Clínics Institut de Salut Global de Barcelona‐ Universitat de Barcelona‐ Hospital Clínic de Barcelona Barcelona, Setembre 2018 El Dr. JORDI VILA ESTAPÉ, Catedràtic del Departament de Fonaments Clínics de la Facultat de Medicina de la Universitat de Barcelona, Cap del Servei de Microbiologia de l’Hospital Clínic de Barcelona i Research Professor i Director de la Iniciativa de Resistències Antimicrobianes de l’Institut de Salut Global de Barcelona (ISGlobal) i la Dra. SARA M. SOTO GONZÁLEZ, Professora Associada del Departament de Fonaments Clínics de la Universitat de Barcelona i Associate Research Professor d’ ISGlobal, CERTIFIQUEN: Que el treball de recerca titulat “Interplay of virulence, antibiotic resistance and epidemiology in Escherichia coli clinical isolates”, presentat per ELISABET GUIRAL VILALTA, ha estat realitzat al Laboratori de Microbiologia de l’ISGlobal, dins les dependències de l’Hospital Clínic de Barcelona, sota la seva direcció i compleix tots els requisits necessaris per la seva tramitació i posterior defensa davant del Tribunal corresponent.
    [Show full text]
  • Human Mucosal Iga Immune Responses Against Enterotoxigenic Escherichia Coli
    pathogens Review Human Mucosal IgA Immune Responses against Enterotoxigenic Escherichia coli Saman Riaz 1,2, Hans Steinsland 3,4 and Kurt Hanevik 1,5,* 1 Department of Clinical Science, University of Bergen, Jonas Lies veg 87, N-5021 Bergen, Norway; [email protected] 2 Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, 5020 Bergen, Norway 3 Centre for Intervention Science in Maternal and Child Health, Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, 5020 Bergen, Norway; [email protected] 4 Department of Biomedicine, University of Bergen, 5020 Bergen, Norway 5 Norwegian National Advisory Unit on Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway * Correspondence: [email protected]; Tel.: +47-5597-5000; Fax: +47-5597-2950 Received: 16 July 2020; Accepted: 24 August 2020; Published: 29 August 2020 Abstract: Infection with enterotoxigenic Escherichia coli (ETEC) is a major contributor to diarrheal illness in children in low- and middle-income countries and travelers to these areas. There is an ongoing effort to develop vaccines against ETEC, and the most reliable immune correlate of protection against ETEC is considered to be the small intestinal secretory IgA response that targets ETEC-specific virulence factors. Since isolating IgA from small intestinal mucosa is technically and ethically challenging, requiring the use of invasive medical procedures, several other indirect methods are used as a proxy for gauging the small intestinal IgA responses. In this review, we summarize the literature reporting on anti-ETEC human IgA responses observed in blood, activated lymphocyte assayss, intestinal lavage/duodenal aspirates, and saliva from human volunteers being experimentally infected with ETEC.
    [Show full text]
  • Shiga Toxin Encoding Bacteriophages and Horizontal Gene Transfer in Escherichia Coli O157
    Shiga toxin encoding bacteriophages and horizontal gene transfer in Escherichia coli O157 Eby Mazini Sim A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy July 2016 Certificate of Authorship/ Originality Certificate of Authorship/Originality I certify that the work presented in this thesis has not previously been submitted for a degree, nor has it been submitted as part of the requirements for a degree except as fully acknowledged within the text. I also certify that the written preparation of the thesis, and all experimental work associated with it, has been carried out solely by me, unless otherwise indicated. Finally, I certify that all information sources and literature used are acknowledged in the text. ____________________________ Eby Mazini Sim i Acknowledgements Acknowledgements My journey as a PhD student, starting from The University of Queensland, Brisbane and the subsequent relocation to The University of Technology, Sydney, has been challenging, exciting and immensely rewarding. However, this thesis would not have been possible without the support and guidance from a number of amazing people along the way. First and foremost, I would like to acknowledge my principal supervisor Dr. Nico Petty. Nico not only supervised the work presented in this thesis and provided feedback on this thesis, she also guided and encouraged me through these years. Her passion for research is truly inspiring. I would also like to acknowledge my co-supervisor Dr. Kari Gobius. In spite of his responsibilities at the CSIRO, Kari always made time to mentor me. Both of my supervisors contributed enormously to my development as a scientist and I couldn’t have asked for a better supervisory team for my PhD journey.
    [Show full text]
  • The Reduction of T7 Phage Adsorption in Escherichia Coli B23 Cells Treated with Sub-Lethal Levels of Kanamycin
    Journal of Experimental Microbiology and Immunology (JEMI) Vol. 13:89-92 Copyright © April 2009, M&I UBC The Reduction of T7 Phage Adsorption in Escherichia coli B23 Cells Treated with Sub-Lethal Levels of Kanamycin Joanne Bleackley, Jesse Cooper, Monica Kaminski and Stephanie Sandilands Department of Microbiology & Immunology, UBC The production of capsular material has been implicated as a bacterial defence mechanism against certain antibiotics and against phage adsorption. The capsule acts to block the phage from binding to its receptor on the bacterial cell which effectively inhibits phage adsorption. Previously, it has been shown that exposing Escherichia coli B23 cells to sub-inhibitory levels of the antibiotic kanamycin results in an increase in extracellular polysaccharide production, possibly in the form of a capsule. In the current study, this phenomenon was investigated using T7 phage adsorption as a model to assess the presence of a capsule. Phage adsorption assays were performed on both E. coli B23 cells treated with sub-lethal levels of kanamycin for 1 hour and untreated cells. T7 phage adsorption was shown to be diminished in E. coli treated with antibiotic, as compared to those which had not been treated with antibiotic. This decrease in phage adsorption to the antibiotic treated cells suggests that the induced extracellular polysaccharide produced by these cells is part of the capsule. Thus, this work provides further insight into the likely nature of the induced-extracellular polysaccharide produced by these cells following antibiotic treatment. Bacteria have developed mechanisms to adapt to phage adsorption (17). Binding of T7 phage to LPS changes in their environment.
    [Show full text]
  • Complete Genome Sequence of the Original Escherichia Coli Strain
    RESEARCH ARTICLE Dunne et al., Microbial Genomics 2017;3 DOI 10.1099/mgen.0.000106 Sequencing a piece of history: complete genome sequence of the original Escherichia coli strain Karl A. Dunne,1 Roy R. Chaudhuri,2 Amanda E. Rossiter,1 Irene Beriotto,1 Douglas F. Browning,1 Derrick Squire,1 Adam F. Cunningham,1 Jeffrey A. Cole,1 Nicholas Loman1 and Ian R. Henderson1,* Abstract In 1885, Theodor Escherich first described the Bacillus coli commune, which was subsequently renamed Escherichia coli. We report the complete genome sequence of this original strain (NCTC 86). The 5 144 392 bp circular chromosome encodes the genes for 4805 proteins, which include antigens, virulence factors, antimicrobial-resistance factors and secretion systems, of a commensal organism from the pre-antibiotic era. It is located in the E. coli A subgroup and is closely related to E. coli K-12 MG1655. E. coli strain NCTC 86 and the non-pathogenic K-12, C, B and HS strains share a common backbone that is largely co-linear. The exception is a large 2 803 932 bp inversion that spans the replication terminus from gmhB to clpB. Comparison with E. coli K-12 reveals 41 regions of difference (577 351 bp) distributed across the chromosome. For example, and contrary to current dogma, E. coli NCTC 86 includes a nine gene sil locus that encodes a silver-resistance efflux pump acquired before the current widespread use of silver nanoparticles as an antibacterial agent, possibly resulting from the widespread use of silver utensils and currency in Germany in the 1800s.
    [Show full text]